Eli Lilly stock outlook 2026: retatrutide opens the next GLP-1 efficacy cycle as the gap with Novo Nordisk widens, against net pricing and a premium valuation.
BOXABL stock nears Nasdaq trading under BXBL after shareholder approval of its FGMC SPAC merger. See the latest valuation, ticker status, risks and outlook.
CMR Green Technologies listed at a 43% premium. See its IPO valuation, financials, recycling leadership, key risks and whether the stock is worth the premium.
Why a 0% currency can stay strong as the Swiss franc holds firm before the 18 June SNB decision, supported by low inflation, safe-haven demand, and credibility.